|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CDK6-ANKIB1 (FusionGDB2 ID:HG1021TG54467) |
Fusion Gene Summary for CDK6-ANKIB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CDK6-ANKIB1 | Fusion gene ID: hg1021tg54467 | Hgene | Tgene | Gene symbol | CDK6 | ANKIB1 | Gene ID | 1021 | 54467 |
Gene name | cyclin dependent kinase 6 | ankyrin repeat and IBR domain containing 1 | |
Synonyms | MCPH12|PLSTIRE | - | |
Cytomap | ('CDK6')('ANKIB1') 7q21.2 | 7q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | cyclin-dependent kinase 6cell division protein kinase 6serine/threonine-protein kinase PLSTIRE | ankyrin repeat and IBR domain-containing protein 1 | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | Q00534 | . | |
Ensembl transtripts involved in fusion gene | ENST00000265734, ENST00000424848, ENST00000491250, | ||
Fusion gene scores | * DoF score | 12 X 9 X 7=756 | 13 X 10 X 8=1040 |
# samples | 17 | 20 | |
** MAII score | log2(17/756*10)=-2.15285148808337 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(20/1040*10)=-2.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CDK6 [Title/Abstract] AND ANKIB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CDK6(92462405)-ANKIB1(91936673), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. CDK6-ANKIB1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CDK6 | GO:0001954 | positive regulation of cell-matrix adhesion | 10205165 |
Hgene | CDK6 | GO:0003323 | type B pancreatic cell development | 20668294 |
Hgene | CDK6 | GO:0006468 | protein phosphorylation | 8114739 |
Hgene | CDK6 | GO:0010468 | regulation of gene expression | 15254224 |
Hgene | CDK6 | GO:0045638 | negative regulation of myeloid cell differentiation | 17431401 |
Hgene | CDK6 | GO:0045656 | negative regulation of monocyte differentiation | 26542173 |
Hgene | CDK6 | GO:0045668 | negative regulation of osteoblast differentiation | 15254224 |
Hgene | CDK6 | GO:0045786 | negative regulation of cell cycle | 14985467 |
Hgene | CDK6 | GO:2000773 | negative regulation of cellular senescence | 17420273 |
Fusion gene breakpoints across CDK6 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ANKIB1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PAAD | TCGA-IB-A5SO-01A | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
ChimerDB4 | STAD | TCGA-RD-A8N6-01A | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
ChimerDB4 | STAD | TCGA-RD-A8N6 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
Top |
Fusion Gene ORF analysis for CDK6-ANKIB1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000265734 | ENST00000265742 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
5CDS-5UTR | ENST00000424848 | ENST00000265742 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
5CDS-intron | ENST00000265734 | ENST00000486698 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
5CDS-intron | ENST00000265734 | ENST00000486698 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
5CDS-intron | ENST00000265734 | ENST00000486698 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
5CDS-intron | ENST00000424848 | ENST00000486698 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
5CDS-intron | ENST00000424848 | ENST00000486698 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
5CDS-intron | ENST00000424848 | ENST00000486698 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
Frame-shift | ENST00000265734 | ENST00000265742 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
Frame-shift | ENST00000265734 | ENST00000265742 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
In-frame | ENST00000424848 | ENST00000265742 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
In-frame | ENST00000424848 | ENST00000265742 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
intron-3CDS | ENST00000491250 | ENST00000265742 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
intron-3CDS | ENST00000491250 | ENST00000265742 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
intron-5UTR | ENST00000491250 | ENST00000265742 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
intron-intron | ENST00000491250 | ENST00000486698 | CDK6 | chr7 | 92404010 | - | ANKIB1 | chr7 | 91924203 | + |
intron-intron | ENST00000491250 | ENST00000486698 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + |
intron-intron | ENST00000491250 | ENST00000486698 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000424848 | CDK6 | chr7 | 92462404 | - | ENST00000265742 | ANKIB1 | chr7 | 91936672 | + | 6234 | 717 | 484 | 3798 | 1104 |
ENST00000424848 | CDK6 | chr7 | 92462405 | - | ENST00000265742 | ANKIB1 | chr7 | 91936673 | + | 6234 | 717 | 484 | 3798 | 1104 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000424848 | ENST00000265742 | CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + | 0.000231393 | 0.99976856 |
ENST00000424848 | ENST00000265742 | CDK6 | chr7 | 92462405 | - | ANKIB1 | chr7 | 91936673 | + | 0.000231393 | 0.99976856 |
Top |
Fusion Genomic Features for CDK6-ANKIB1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + | 0.000401369 | 0.9995987 |
CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + | 0.000401369 | 0.9995987 |
CDK6 | chr7 | 92404009 | - | ANKIB1 | chr7 | 91924202 | + | 3.96E-06 | 0.99999607 |
CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + | 0.000401369 | 0.9995987 |
CDK6 | chr7 | 92462404 | - | ANKIB1 | chr7 | 91936672 | + | 0.000401369 | 0.9995987 |
CDK6 | chr7 | 92404009 | - | ANKIB1 | chr7 | 91924202 | + | 3.96E-06 | 0.99999607 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CDK6-ANKIB1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:92462405/chr7:91936673) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CDK6 | . |
FUNCTION: Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and regulates negatively cell differentiation, but is required for the proliferation of specific cell types (e.g. erythroid and hematopoietic cells). Essential for cell proliferation within the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. Required during thymocyte development. Promotes the production of newborn neurons, probably by modulating G1 length. Promotes, at least in astrocytes, changes in patterns of gene expression, changes in the actin cytoskeleton including loss of stress fibers, and enhanced motility during cell differentiation. Prevents myeloid differentiation by interfering with RUNX1 and reducing its transcription transactivation activity, but promotes proliferation of normal myeloid progenitors. Delays senescence. Promotes the proliferation of beta-cells in pancreatic islets of Langerhans. May play a role in the centrosome organization during the cell cycle phases (PubMed:23918663). {ECO:0000269|PubMed:12833137, ECO:0000269|PubMed:14985467, ECO:0000269|PubMed:15254224, ECO:0000269|PubMed:15809340, ECO:0000269|PubMed:17420273, ECO:0000269|PubMed:17431401, ECO:0000269|PubMed:20333249, ECO:0000269|PubMed:20668294, ECO:0000269|PubMed:23918663, ECO:0000269|PubMed:8114739}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CDK6 | chr7:92462404 | chr7:91936672 | ENST00000265734 | - | 2 | 8 | 19_27 | 77 | 327.0 | Nucleotide binding | ATP |
Hgene | CDK6 | chr7:92462404 | chr7:91936672 | ENST00000424848 | - | 2 | 8 | 19_27 | 77 | 327.0 | Nucleotide binding | ATP |
Hgene | CDK6 | chr7:92462405 | chr7:91936673 | ENST00000265734 | - | 2 | 8 | 19_27 | 77 | 327.0 | Nucleotide binding | ATP |
Hgene | CDK6 | chr7:92462405 | chr7:91936673 | ENST00000424848 | - | 2 | 8 | 19_27 | 77 | 327.0 | Nucleotide binding | ATP |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 575_640 | 62 | 1090.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 575_640 | 62 | 1090.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 851_870 | 62 | 1090.0 | Domain | UIM | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 851_870 | 62 | 1090.0 | Domain | UIM | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 329_569 | 62 | 1090.0 | Region | TRIAD supradomain | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 329_569 | 62 | 1090.0 | Region | TRIAD supradomain | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 144_173 | 62 | 1090.0 | Repeat | Note=ANK 2 | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 144_173 | 62 | 1090.0 | Repeat | Note=ANK 2 | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 333_383 | 62 | 1090.0 | Zinc finger | RING-type 1 | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 401_478 | 62 | 1090.0 | Zinc finger | IBR-type | |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 519_548 | 62 | 1090.0 | Zinc finger | RING-type 2%3B atypical | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 333_383 | 62 | 1090.0 | Zinc finger | RING-type 1 | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 401_478 | 62 | 1090.0 | Zinc finger | IBR-type | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 519_548 | 62 | 1090.0 | Zinc finger | RING-type 2%3B atypical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CDK6 | chr7:92462404 | chr7:91936672 | ENST00000265734 | - | 2 | 8 | 13_300 | 77 | 327.0 | Domain | Protein kinase |
Hgene | CDK6 | chr7:92462404 | chr7:91936672 | ENST00000424848 | - | 2 | 8 | 13_300 | 77 | 327.0 | Domain | Protein kinase |
Hgene | CDK6 | chr7:92462405 | chr7:91936673 | ENST00000265734 | - | 2 | 8 | 13_300 | 77 | 327.0 | Domain | Protein kinase |
Hgene | CDK6 | chr7:92462405 | chr7:91936673 | ENST00000424848 | - | 2 | 8 | 13_300 | 77 | 327.0 | Domain | Protein kinase |
Tgene | ANKIB1 | chr7:92462404 | chr7:91936672 | ENST00000265742 | 1 | 20 | 45_74 | 62 | 1090.0 | Repeat | Note=ANK 1 | |
Tgene | ANKIB1 | chr7:92462405 | chr7:91936673 | ENST00000265742 | 1 | 20 | 45_74 | 62 | 1090.0 | Repeat | Note=ANK 1 |
Top |
Fusion Gene Sequence for CDK6-ANKIB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>15287_15287_1_CDK6-ANKIB1_CDK6_chr7_92462404_ENST00000424848_ANKIB1_chr7_91936672_ENST00000265742_length(transcript)=6234nt_BP=717nt GCTGGTAACTCCTTCCCCAGAGTCTGATTACCTGCTCCGCGAGGCCGCGGACACGTGCGGAGAGCCGACTGACACTCGCAGCCCCCTCGG GAGGCCCGACGCGACTGGGCCCCTCAGGTGCAATGATTCTGGACTGAGACGCGCTTGGGCAGAGGCTATGTAATCGTGTCTGTGTTGAGG ACTTCGCTTCGAGGAGGGAAGAGGAGGGATCGGCTCGCTCCTCCGGCGGCGGCGGCGGCGGCGACTCTGCAGGCGGAGTTTCGCGGCGGC GGCACCAGGGTTACGCCAGCCCCGCGGGGAGGTCTCTCCATCCAGCTTCTGCAGCGGCGAAAGCCCCAGCGCCCGAGCGCCTGAGCCGGC GGGGAGCAAGTAAAGCTAGACCGATCTCCGGGGAGCCCCGGAGTAGGCGAGCGGCGGCCGCCAGCTAGTTGAGCGCACCCCCCGCCCGCC CCAGCGGCGCCGCGGCGGGCGGCGTCCAGGCGGCATGGAGAAGGACGGCCTGTGCCGCGCTGACCAGCAGTACGAATGCGTGGCGGAGAT CGGGGAGGGCGCCTATGGGAAGGTGTTCAAGGCCCGCGACTTGAAGAACGGAGGCCGTTTCGTGGCGTTGAAGCGCGTGCGGGTGCAGAC CGGCGAGGAGGGCATGCCGCTCTCCACCATCCGCGAGGTGGCGGTGCTGAGGCACCTGGAGACCTTCGAGCACCCCAACGTGGTCAGGAC TTTTCTTGGTAGAGATGGAAATCCAAATAAACGGAATGTGCACAATGAAACATCTATGCATTTGTTGTGTATGGGACCTCAAATTATGAT ATCTGAAGGAGCCCTTCATCCTCGCTTGGCACGCCCCACAGAAGATGATTTCAGAAGAGCAGATTGTCTGCAGATGATCTTAAAATGGAA AGGAGCAAAACTTGACCAGGGTGAATATGAGAGAGCAGCTATTGATGCTGTTGATAACAAAAAAAACACACCCTTGCACTATGCTGCTGC CTCAGGGATGAAAGCCTGTGTAGAGCTTTTAGTAAAACATGGAGGAGACTTGTTTGCTGAGAATGAAAATAAAGATACTCCTTGTGATTG TGCTGAAAAGCAACACCACAAAGATTTGGCCCTCAATCTGGAATCTCAAATGGTATTCTCACGGGATCCCGAGGCTGAAGAAATAGAAGC TGAATATGCTGCATTAGACAAACGAGAGCCATATGAAGGATTAAGGCCTCAGGATCTTCGTAGACTAAAAGATATGCTTATTGTGGAAAC TGCAGACATGCTTCAGGCTCCTCTCTTTACTGCTGAAGCTTTACTTCGAGCTCATGACTGGGACAGGGAGAAATTACTTGAAGCTTGGAT GTCCAACCCGGAGAACTGCTGCCAACGATCAGGTGTTCAAATGCCAACTCCACCACCAAGTGGGTATAATGCCTGGGACACGCTCCCATC TCCAAGAACTCCAAGGACTACACGCTCTTCTGTCACCTCCCCAGATGAAATCAGCTTATCTCCTGGGGATTTAGACACCAGTTTGTGTGA CATTTGTATGTGCAGTATCTCTGTATTTGAAGACCCTGTGGATATGCCCTGTGGACATGACTTTTGTAGAGGATGTTGGGAGTCGTTTTT GAATCTGAAAATTCAAGAAGGTGAAGCTCACAACATTTTTTGCCCTGCATATGATTGCTTCCAACTTGTACCTGTGGATATCATAGAAAG TGTAGTTTCAAAGGAGATGGACAAACGATACCTACAGTTTGATATTAAGGCCTTTGTTGAAAATAATCCTGCCATTAAATGGTGTCCTAC TCCAGGCTGTGACAGAGCAGTAAGACTAACGAAACAAGGGTCAAATACATCTGGATCTGATACACTCAGCTTCCCATTGCTGAGAGCTCC TGCTGTTGATTGTGGAAAAGGACACCTCTTCTGCTGGGAGTGCCTTGGTGAAGCACATGAGCCTTGTGACTGCCAAACATGGAAGAATTG GCTGCAAAAAATAACCGAAATGAAACCAGAAGAACTTGTGGGAGTTAGTGAAGCCTACGAGGATGCCGCCAATTGTCTCTGGTTATTAAC TAACTCCAAGCCTTGTGCCAACTGTAAGTCTCCAATACAGAAGAATGAAGGCTGCAATCACATGCAGTGTGCTAAGTGCAAGTATGACTT TTGCTGGATTTGCCTTGAAGAGTGGAAAAAACATAGTTCGTCCACTGGAGGTTATTACAGATGTACTCGCTATGAAGTCATTCAACACGT GGAGGAGCAATCCAAGGAAATGACTGTGGAGGCTGAGAAAAAACACAAACGATTTCAGGAACTTGACAGATTTATGCACTATTATACAAG ATTTAAAAACCATGAGCATAGTTATCAGCTAGAACAACGCCTTCTTAAAACAGCCAAAGAAAAGATGGAGCAATTGAGCAGAGCTCTCAA AGAAACTGAAGGAGGCTGTCCAGATACCACTTTCATTGAAGATGCAGTTCATGTGCTCTTAAAAACTCGGCGCATTCTCAAGTGTTCTTA TCCATATGGATTTTTCTTGGAACCTAAAAGCACAAAGAAAGAAATTTTTGAACTAATGCAAACAGACCTAGAAATGGTCACTGAAGACCT TGCCCAGAAAGTCAATAGGCCTTACCTTCGCACACCCCGCCACAAGATCATCAAAGCAGCATGCCTTGTACAGCAGAAGAGGCAAGAATT CCTGGCATCTGTGGCTCGGGGAGTAGCTCCTGCAGACTCACCAGAAGCTCCAAGGCGCAGCTTTGCTGGTGGAACATGGGATTGGGAATA TTTAGGATTTGCATCACCAGAGGAATATGCTGAATTTCAGTATCGGAGGAGGCACAGACAACGTCGTCGAGGAGATGTTCACAGTCTACT CAGTAATCCTCCAGACCCTGATGAGCCAAGTGAAAGCACTTTAGATATTCCAGAAGGCGGCAGCAGCAGCCGCAGGCCTGGCACATCCGT GGTAAGTTCTGCATCTATGAGTGTGCTGCACAGCTCTTCCCTGCGTGACTACACCCCTGCCAGTCGCTCTGAAAACCAGGACTCTCTTCA GGCTCTGAGTTCCTTGGATGAAGACGATCCCAATATACTTCTTGCAATACAGTTATCACTGCAAGAGTCTGGGCTGGCCCTCGATGAAGA AACTAGAGACTTCCTCAGTAATGAAGCATCCTTAGGTGCGATAGGCACTTCTTTACCTTCCAGGCTGGACTCTGTCCCCAGAAATACAGA TAGCCCTCGGGCTGCATTGAGCAGCTCTGAGCTTTTGGAACTTGGTGACAGCCTCATGAGACTAGGAGCAGAGAATGACCCATTTTCAAC TGACACCCTGAGCTCACACCCTCTCAGTGAGGCAAGAAGTGATTTCTGTCCCTCATCTAGTGATCCTGACTCAGCTGGCCAGGACCCCAA CATCAATGACAATCTTCTCGGCAACATCATGGCTTGGTTTCATGACATGAACCCTCAGAGTATTGCCCTGATTCCTCCAGCAACTACAGA AATCAGTGCAGATTCCCAGCTCCCCTGTATCAAAGATGGGTCAGAAGGTGTGAAGGATGTGGAACTGGTGCTGCCAGAAGATTCAATGTT TGAAGATGCCAGTGTCAGTGAAGGTAGAGGAACCCAGATAGAAGAAAATCCTTTGGAAGAAAATATTCTGGCGGGGGAAGCAGCATCTCA AGCTGGTGACAGTGGTAACGAGGCAGCCAACAGAGGAGATGGTTCAGATGTTTCAAGTCAAACACCTCAAACCTCAAGTGACTGGCTTGA ACAAGTACATTTAGTGTGAACTGCACACATCTGGGCTCTAAATGAATTACAGGTACAGATGGTATGCTAGGTGGAGTATGCTTGATAGAG ACTTTGATTCACTTAATTCCAACTCAGTGATAAACCACTGACATTAGGGTTGAATACAGAGAAGTTCCCTTGAATGGTAGCTTCATTTTT TATTTTAACCTTACAGGGAATTTCCTTTGTACTTAATTGAATAGCTTTTCCCCTTTTTGCTGACAAAAAGAAGAGCAAGAGAAAGAGAAA CAAAAATGAAATAAATAAGTTGTATTCCACACTCTAAGAAAATGCAGTCCTCTATTTAGCCTAGGCTTGACAATACTTAAATTGAACATT TAAACTAAAGGCTTACTCCCTAATCTTTGGGTGGCTTTCCTTTAAAAAAAAAAAAAAAGTTTTCTTCATTCTAGAAATTTATTTTGGATA AATCCGATAACATATATGTCCTCAATCTCTTTGTGCTCTTCCATAACTTACTTCCTTTTTGTCTGAGCAATGTGAATTGAAGTCTCTTTA GTACCACATCTACCATAGTGTAATTAGTTTTAATTTTCACATGAATCAAAGGTTTCCTTTCATGTCTATTTACAGTCCAATTGTGCCAAA CTCTTACTTGTGTGCTGACTAACAAGGCATTTAGGTGTGCAGCATCCTAGAGTGCTCCAGGGCAGTGTCAGCGTTCTCGGGAGTAAAAGG TGCCACTTGGTAGCAATGATATTCCAGAATTAAATGGGTTTTTGTTGCCATGGAGACTGCATTTATATAAATGTAGCCTGTAGCTTAAGT TAACTAAACCTAATGCTGCTGTTAAAAACAGTTTATTTTAATATTAAAATACAGTTGATTAGCAACAGCGGTGCTGTATTTTAAGAGACA CTTTATTGGAAGTGCAATCATAGTTATTTGTTTTCACAATTTTACAGTGCATTCTAATTACTGATGGGTGCAATTACTTTTAATCGTGTT TTATAAAATAGAAAAAAAGTGGAGTTTTCATGAGTTATAGTAAATCCCACGATTATTAAGAAATTCAGTAAAACATCCTGCGCAACATGT TACCGTGCCTTTGCCTAACCTAAATGGATAGTTGCCAGTTAAATAAGTGAGTAATTCAAATTTCAATGTCTCTTCTGAAGTAACTATGCT ATGAATTGCAAAGACCTCCATAAAACCACCCATGGCCTTGCTTTTACACTAACTATAACAACTAAATGTTCAATCAGTTTGTTTGCCTAA CTAGCAAATGCTGACATGTGTTTGTTCTACTGCGCAATACTCATTTGCTGTGTGATTACTGTTTAGTGTTGAAAAAAATCAACTTCCTAG TTATCAGTGTCTTACTGTGAAGAAAATACTGGTCTTAGTTGTAATTAGGATACAATGGTACAGTGTGTAATTAAAACTAGAGTAAACTGT TGGAATGGCTGTTTTACTTAAATATTATCAAAACTAGCATAACATAAGCAAAATAGATAAGTACAACACTCCATTTAGTGTTTTGCCAGA TTGTTACCAGAAGTCTACAGATACCAAACTTTCAGTTCTGAGTTTGTACAGGCAAGTCCTGGGCTGGGTAAAAAGTTATATTAATATTGT TATCCACAAGAGATGTGATTATGGGTTTTGATTACTTTTTTTTTTTCCAAACCCTGCTTTTGAAATATCCTTGTACTTAAAATTCATATT GCTAAGACACTGTATTAGAATATTTAATATTCCCCAGATCCTCTTAGGATAAACTGTGGGAATCCTCCTATGCCATGGATATCAAAGGTC CACATTAGTTTTTATTTCTCCAGTGATCAGAAACATTGATATCAATCCCTATTAAATTAGTGGGGGGAATATTAACTTTATCTACAGTGT ATTACTGTATATTAAACTGAAATAGTCCATTAAAGGATTTTTTTATAAATTTATTTTGGATTAAAAATATCAACACCAATAAGTTTTTAG ACCAAGTTGTAATTTTTCCAATATAGAGTCTTTGCATCACACTGAGGCATCTTGCACAGCTGCAGTTAAGGTGAGAAAGAATGCTCTGTG TGAAGACAGTGTACACAATGGGTTCCGGTTTCCTTGCACCTTGTGCAGTATCCTTTATTTCTGTGCTGTTCTCTCCTGAGCATGAAAAAT GATCATTATCCAATTTGTATTTCCTTGGTACATATTTTAAAAACAACACAGTCATTGACTTTACAATTCAGTAATGAAGTTTGGCAAAGC CTATTTTGTAAACAAGTTAATTTTATAATGTAAAAAAAAAAAGTTAATCTAACCTTGACTTGTTATTTGCACTTTCATAGTCTATACTTG ATACATTCCCACTTTATATACAGTAGGATTCTACAAACGTGTAGATGTTTGGCCAAATGAATGCTGTTAATAATATGTAAAATTCTTTGA >15287_15287_1_CDK6-ANKIB1_CDK6_chr7_92462404_ENST00000424848_ANKIB1_chr7_91936672_ENST00000265742_length(amino acids)=1104AA_BP=77 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRTFLGRDGNPNKR NVHNETSMHLLCMGPQIMISEGALHPRLARPTEDDFRRADCLQMILKWKGAKLDQGEYERAAIDAVDNKKNTPLHYAAASGMKACVELLV KHGGDLFAENENKDTPCDCAEKQHHKDLALNLESQMVFSRDPEAEEIEAEYAALDKREPYEGLRPQDLRRLKDMLIVETADMLQAPLFTA EALLRAHDWDREKLLEAWMSNPENCCQRSGVQMPTPPPSGYNAWDTLPSPRTPRTTRSSVTSPDEISLSPGDLDTSLCDICMCSISVFED PVDMPCGHDFCRGCWESFLNLKIQEGEAHNIFCPAYDCFQLVPVDIIESVVSKEMDKRYLQFDIKAFVENNPAIKWCPTPGCDRAVRLTK QGSNTSGSDTLSFPLLRAPAVDCGKGHLFCWECLGEAHEPCDCQTWKNWLQKITEMKPEELVGVSEAYEDAANCLWLLTNSKPCANCKSP IQKNEGCNHMQCAKCKYDFCWICLEEWKKHSSSTGGYYRCTRYEVIQHVEEQSKEMTVEAEKKHKRFQELDRFMHYYTRFKNHEHSYQLE QRLLKTAKEKMEQLSRALKETEGGCPDTTFIEDAVHVLLKTRRILKCSYPYGFFLEPKSTKKEIFELMQTDLEMVTEDLAQKVNRPYLRT PRHKIIKAACLVQQKRQEFLASVARGVAPADSPEAPRRSFAGGTWDWEYLGFASPEEYAEFQYRRRHRQRRRGDVHSLLSNPPDPDEPSE STLDIPEGGSSSRRPGTSVVSSASMSVLHSSSLRDYTPASRSENQDSLQALSSLDEDDPNILLAIQLSLQESGLALDEETRDFLSNEASL GAIGTSLPSRLDSVPRNTDSPRAALSSSELLELGDSLMRLGAENDPFSTDTLSSHPLSEARSDFCPSSSDPDSAGQDPNINDNLLGNIMA WFHDMNPQSIALIPPATTEISADSQLPCIKDGSEGVKDVELVLPEDSMFEDASVSEGRGTQIEENPLEENILAGEAASQAGDSGNEAANR -------------------------------------------------------------- >15287_15287_2_CDK6-ANKIB1_CDK6_chr7_92462405_ENST00000424848_ANKIB1_chr7_91936673_ENST00000265742_length(transcript)=6234nt_BP=717nt GCTGGTAACTCCTTCCCCAGAGTCTGATTACCTGCTCCGCGAGGCCGCGGACACGTGCGGAGAGCCGACTGACACTCGCAGCCCCCTCGG GAGGCCCGACGCGACTGGGCCCCTCAGGTGCAATGATTCTGGACTGAGACGCGCTTGGGCAGAGGCTATGTAATCGTGTCTGTGTTGAGG ACTTCGCTTCGAGGAGGGAAGAGGAGGGATCGGCTCGCTCCTCCGGCGGCGGCGGCGGCGGCGACTCTGCAGGCGGAGTTTCGCGGCGGC GGCACCAGGGTTACGCCAGCCCCGCGGGGAGGTCTCTCCATCCAGCTTCTGCAGCGGCGAAAGCCCCAGCGCCCGAGCGCCTGAGCCGGC GGGGAGCAAGTAAAGCTAGACCGATCTCCGGGGAGCCCCGGAGTAGGCGAGCGGCGGCCGCCAGCTAGTTGAGCGCACCCCCCGCCCGCC CCAGCGGCGCCGCGGCGGGCGGCGTCCAGGCGGCATGGAGAAGGACGGCCTGTGCCGCGCTGACCAGCAGTACGAATGCGTGGCGGAGAT CGGGGAGGGCGCCTATGGGAAGGTGTTCAAGGCCCGCGACTTGAAGAACGGAGGCCGTTTCGTGGCGTTGAAGCGCGTGCGGGTGCAGAC CGGCGAGGAGGGCATGCCGCTCTCCACCATCCGCGAGGTGGCGGTGCTGAGGCACCTGGAGACCTTCGAGCACCCCAACGTGGTCAGGAC TTTTCTTGGTAGAGATGGAAATCCAAATAAACGGAATGTGCACAATGAAACATCTATGCATTTGTTGTGTATGGGACCTCAAATTATGAT ATCTGAAGGAGCCCTTCATCCTCGCTTGGCACGCCCCACAGAAGATGATTTCAGAAGAGCAGATTGTCTGCAGATGATCTTAAAATGGAA AGGAGCAAAACTTGACCAGGGTGAATATGAGAGAGCAGCTATTGATGCTGTTGATAACAAAAAAAACACACCCTTGCACTATGCTGCTGC CTCAGGGATGAAAGCCTGTGTAGAGCTTTTAGTAAAACATGGAGGAGACTTGTTTGCTGAGAATGAAAATAAAGATACTCCTTGTGATTG TGCTGAAAAGCAACACCACAAAGATTTGGCCCTCAATCTGGAATCTCAAATGGTATTCTCACGGGATCCCGAGGCTGAAGAAATAGAAGC TGAATATGCTGCATTAGACAAACGAGAGCCATATGAAGGATTAAGGCCTCAGGATCTTCGTAGACTAAAAGATATGCTTATTGTGGAAAC TGCAGACATGCTTCAGGCTCCTCTCTTTACTGCTGAAGCTTTACTTCGAGCTCATGACTGGGACAGGGAGAAATTACTTGAAGCTTGGAT GTCCAACCCGGAGAACTGCTGCCAACGATCAGGTGTTCAAATGCCAACTCCACCACCAAGTGGGTATAATGCCTGGGACACGCTCCCATC TCCAAGAACTCCAAGGACTACACGCTCTTCTGTCACCTCCCCAGATGAAATCAGCTTATCTCCTGGGGATTTAGACACCAGTTTGTGTGA CATTTGTATGTGCAGTATCTCTGTATTTGAAGACCCTGTGGATATGCCCTGTGGACATGACTTTTGTAGAGGATGTTGGGAGTCGTTTTT GAATCTGAAAATTCAAGAAGGTGAAGCTCACAACATTTTTTGCCCTGCATATGATTGCTTCCAACTTGTACCTGTGGATATCATAGAAAG TGTAGTTTCAAAGGAGATGGACAAACGATACCTACAGTTTGATATTAAGGCCTTTGTTGAAAATAATCCTGCCATTAAATGGTGTCCTAC TCCAGGCTGTGACAGAGCAGTAAGACTAACGAAACAAGGGTCAAATACATCTGGATCTGATACACTCAGCTTCCCATTGCTGAGAGCTCC TGCTGTTGATTGTGGAAAAGGACACCTCTTCTGCTGGGAGTGCCTTGGTGAAGCACATGAGCCTTGTGACTGCCAAACATGGAAGAATTG GCTGCAAAAAATAACCGAAATGAAACCAGAAGAACTTGTGGGAGTTAGTGAAGCCTACGAGGATGCCGCCAATTGTCTCTGGTTATTAAC TAACTCCAAGCCTTGTGCCAACTGTAAGTCTCCAATACAGAAGAATGAAGGCTGCAATCACATGCAGTGTGCTAAGTGCAAGTATGACTT TTGCTGGATTTGCCTTGAAGAGTGGAAAAAACATAGTTCGTCCACTGGAGGTTATTACAGATGTACTCGCTATGAAGTCATTCAACACGT GGAGGAGCAATCCAAGGAAATGACTGTGGAGGCTGAGAAAAAACACAAACGATTTCAGGAACTTGACAGATTTATGCACTATTATACAAG ATTTAAAAACCATGAGCATAGTTATCAGCTAGAACAACGCCTTCTTAAAACAGCCAAAGAAAAGATGGAGCAATTGAGCAGAGCTCTCAA AGAAACTGAAGGAGGCTGTCCAGATACCACTTTCATTGAAGATGCAGTTCATGTGCTCTTAAAAACTCGGCGCATTCTCAAGTGTTCTTA TCCATATGGATTTTTCTTGGAACCTAAAAGCACAAAGAAAGAAATTTTTGAACTAATGCAAACAGACCTAGAAATGGTCACTGAAGACCT TGCCCAGAAAGTCAATAGGCCTTACCTTCGCACACCCCGCCACAAGATCATCAAAGCAGCATGCCTTGTACAGCAGAAGAGGCAAGAATT CCTGGCATCTGTGGCTCGGGGAGTAGCTCCTGCAGACTCACCAGAAGCTCCAAGGCGCAGCTTTGCTGGTGGAACATGGGATTGGGAATA TTTAGGATTTGCATCACCAGAGGAATATGCTGAATTTCAGTATCGGAGGAGGCACAGACAACGTCGTCGAGGAGATGTTCACAGTCTACT CAGTAATCCTCCAGACCCTGATGAGCCAAGTGAAAGCACTTTAGATATTCCAGAAGGCGGCAGCAGCAGCCGCAGGCCTGGCACATCCGT GGTAAGTTCTGCATCTATGAGTGTGCTGCACAGCTCTTCCCTGCGTGACTACACCCCTGCCAGTCGCTCTGAAAACCAGGACTCTCTTCA GGCTCTGAGTTCCTTGGATGAAGACGATCCCAATATACTTCTTGCAATACAGTTATCACTGCAAGAGTCTGGGCTGGCCCTCGATGAAGA AACTAGAGACTTCCTCAGTAATGAAGCATCCTTAGGTGCGATAGGCACTTCTTTACCTTCCAGGCTGGACTCTGTCCCCAGAAATACAGA TAGCCCTCGGGCTGCATTGAGCAGCTCTGAGCTTTTGGAACTTGGTGACAGCCTCATGAGACTAGGAGCAGAGAATGACCCATTTTCAAC TGACACCCTGAGCTCACACCCTCTCAGTGAGGCAAGAAGTGATTTCTGTCCCTCATCTAGTGATCCTGACTCAGCTGGCCAGGACCCCAA CATCAATGACAATCTTCTCGGCAACATCATGGCTTGGTTTCATGACATGAACCCTCAGAGTATTGCCCTGATTCCTCCAGCAACTACAGA AATCAGTGCAGATTCCCAGCTCCCCTGTATCAAAGATGGGTCAGAAGGTGTGAAGGATGTGGAACTGGTGCTGCCAGAAGATTCAATGTT TGAAGATGCCAGTGTCAGTGAAGGTAGAGGAACCCAGATAGAAGAAAATCCTTTGGAAGAAAATATTCTGGCGGGGGAAGCAGCATCTCA AGCTGGTGACAGTGGTAACGAGGCAGCCAACAGAGGAGATGGTTCAGATGTTTCAAGTCAAACACCTCAAACCTCAAGTGACTGGCTTGA ACAAGTACATTTAGTGTGAACTGCACACATCTGGGCTCTAAATGAATTACAGGTACAGATGGTATGCTAGGTGGAGTATGCTTGATAGAG ACTTTGATTCACTTAATTCCAACTCAGTGATAAACCACTGACATTAGGGTTGAATACAGAGAAGTTCCCTTGAATGGTAGCTTCATTTTT TATTTTAACCTTACAGGGAATTTCCTTTGTACTTAATTGAATAGCTTTTCCCCTTTTTGCTGACAAAAAGAAGAGCAAGAGAAAGAGAAA CAAAAATGAAATAAATAAGTTGTATTCCACACTCTAAGAAAATGCAGTCCTCTATTTAGCCTAGGCTTGACAATACTTAAATTGAACATT TAAACTAAAGGCTTACTCCCTAATCTTTGGGTGGCTTTCCTTTAAAAAAAAAAAAAAAGTTTTCTTCATTCTAGAAATTTATTTTGGATA AATCCGATAACATATATGTCCTCAATCTCTTTGTGCTCTTCCATAACTTACTTCCTTTTTGTCTGAGCAATGTGAATTGAAGTCTCTTTA GTACCACATCTACCATAGTGTAATTAGTTTTAATTTTCACATGAATCAAAGGTTTCCTTTCATGTCTATTTACAGTCCAATTGTGCCAAA CTCTTACTTGTGTGCTGACTAACAAGGCATTTAGGTGTGCAGCATCCTAGAGTGCTCCAGGGCAGTGTCAGCGTTCTCGGGAGTAAAAGG TGCCACTTGGTAGCAATGATATTCCAGAATTAAATGGGTTTTTGTTGCCATGGAGACTGCATTTATATAAATGTAGCCTGTAGCTTAAGT TAACTAAACCTAATGCTGCTGTTAAAAACAGTTTATTTTAATATTAAAATACAGTTGATTAGCAACAGCGGTGCTGTATTTTAAGAGACA CTTTATTGGAAGTGCAATCATAGTTATTTGTTTTCACAATTTTACAGTGCATTCTAATTACTGATGGGTGCAATTACTTTTAATCGTGTT TTATAAAATAGAAAAAAAGTGGAGTTTTCATGAGTTATAGTAAATCCCACGATTATTAAGAAATTCAGTAAAACATCCTGCGCAACATGT TACCGTGCCTTTGCCTAACCTAAATGGATAGTTGCCAGTTAAATAAGTGAGTAATTCAAATTTCAATGTCTCTTCTGAAGTAACTATGCT ATGAATTGCAAAGACCTCCATAAAACCACCCATGGCCTTGCTTTTACACTAACTATAACAACTAAATGTTCAATCAGTTTGTTTGCCTAA CTAGCAAATGCTGACATGTGTTTGTTCTACTGCGCAATACTCATTTGCTGTGTGATTACTGTTTAGTGTTGAAAAAAATCAACTTCCTAG TTATCAGTGTCTTACTGTGAAGAAAATACTGGTCTTAGTTGTAATTAGGATACAATGGTACAGTGTGTAATTAAAACTAGAGTAAACTGT TGGAATGGCTGTTTTACTTAAATATTATCAAAACTAGCATAACATAAGCAAAATAGATAAGTACAACACTCCATTTAGTGTTTTGCCAGA TTGTTACCAGAAGTCTACAGATACCAAACTTTCAGTTCTGAGTTTGTACAGGCAAGTCCTGGGCTGGGTAAAAAGTTATATTAATATTGT TATCCACAAGAGATGTGATTATGGGTTTTGATTACTTTTTTTTTTTCCAAACCCTGCTTTTGAAATATCCTTGTACTTAAAATTCATATT GCTAAGACACTGTATTAGAATATTTAATATTCCCCAGATCCTCTTAGGATAAACTGTGGGAATCCTCCTATGCCATGGATATCAAAGGTC CACATTAGTTTTTATTTCTCCAGTGATCAGAAACATTGATATCAATCCCTATTAAATTAGTGGGGGGAATATTAACTTTATCTACAGTGT ATTACTGTATATTAAACTGAAATAGTCCATTAAAGGATTTTTTTATAAATTTATTTTGGATTAAAAATATCAACACCAATAAGTTTTTAG ACCAAGTTGTAATTTTTCCAATATAGAGTCTTTGCATCACACTGAGGCATCTTGCACAGCTGCAGTTAAGGTGAGAAAGAATGCTCTGTG TGAAGACAGTGTACACAATGGGTTCCGGTTTCCTTGCACCTTGTGCAGTATCCTTTATTTCTGTGCTGTTCTCTCCTGAGCATGAAAAAT GATCATTATCCAATTTGTATTTCCTTGGTACATATTTTAAAAACAACACAGTCATTGACTTTACAATTCAGTAATGAAGTTTGGCAAAGC CTATTTTGTAAACAAGTTAATTTTATAATGTAAAAAAAAAAAGTTAATCTAACCTTGACTTGTTATTTGCACTTTCATAGTCTATACTTG ATACATTCCCACTTTATATACAGTAGGATTCTACAAACGTGTAGATGTTTGGCCAAATGAATGCTGTTAATAATATGTAAAATTCTTTGA >15287_15287_2_CDK6-ANKIB1_CDK6_chr7_92462405_ENST00000424848_ANKIB1_chr7_91936673_ENST00000265742_length(amino acids)=1104AA_BP=77 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRTFLGRDGNPNKR NVHNETSMHLLCMGPQIMISEGALHPRLARPTEDDFRRADCLQMILKWKGAKLDQGEYERAAIDAVDNKKNTPLHYAAASGMKACVELLV KHGGDLFAENENKDTPCDCAEKQHHKDLALNLESQMVFSRDPEAEEIEAEYAALDKREPYEGLRPQDLRRLKDMLIVETADMLQAPLFTA EALLRAHDWDREKLLEAWMSNPENCCQRSGVQMPTPPPSGYNAWDTLPSPRTPRTTRSSVTSPDEISLSPGDLDTSLCDICMCSISVFED PVDMPCGHDFCRGCWESFLNLKIQEGEAHNIFCPAYDCFQLVPVDIIESVVSKEMDKRYLQFDIKAFVENNPAIKWCPTPGCDRAVRLTK QGSNTSGSDTLSFPLLRAPAVDCGKGHLFCWECLGEAHEPCDCQTWKNWLQKITEMKPEELVGVSEAYEDAANCLWLLTNSKPCANCKSP IQKNEGCNHMQCAKCKYDFCWICLEEWKKHSSSTGGYYRCTRYEVIQHVEEQSKEMTVEAEKKHKRFQELDRFMHYYTRFKNHEHSYQLE QRLLKTAKEKMEQLSRALKETEGGCPDTTFIEDAVHVLLKTRRILKCSYPYGFFLEPKSTKKEIFELMQTDLEMVTEDLAQKVNRPYLRT PRHKIIKAACLVQQKRQEFLASVARGVAPADSPEAPRRSFAGGTWDWEYLGFASPEEYAEFQYRRRHRQRRRGDVHSLLSNPPDPDEPSE STLDIPEGGSSSRRPGTSVVSSASMSVLHSSSLRDYTPASRSENQDSLQALSSLDEDDPNILLAIQLSLQESGLALDEETRDFLSNEASL GAIGTSLPSRLDSVPRNTDSPRAALSSSELLELGDSLMRLGAENDPFSTDTLSSHPLSEARSDFCPSSSDPDSAGQDPNINDNLLGNIMA WFHDMNPQSIALIPPATTEISADSQLPCIKDGSEGVKDVELVLPEDSMFEDASVSEGRGTQIEENPLEENILAGEAASQAGDSGNEAANR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CDK6-ANKIB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDK6-ANKIB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CDK6 | Q00534 | DB09073 | Palbociclib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | CDK6 | Q00534 | DB09073 | Palbociclib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | CDK6 | Q00534 | DB11730 | Ribociclib | Antagonist|Inhibitor | Small molecule | Approved|Investigational |
Hgene | CDK6 | Q00534 | DB11730 | Ribociclib | Antagonist|Inhibitor | Small molecule | Approved|Investigational |
Hgene | CDK6 | Q00534 | DB12001 | Abemaciclib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | CDK6 | Q00534 | DB12001 | Abemaciclib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for CDK6-ANKIB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDK6 | C0004238 | Atrial Fibrillation | 2 | CTD_human |
Hgene | CDK6 | C0025149 | Medulloblastoma | 2 | CTD_human |
Hgene | CDK6 | C0205833 | Medullomyoblastoma | 2 | CTD_human |
Hgene | CDK6 | C0235480 | Paroxysmal atrial fibrillation | 2 | CTD_human |
Hgene | CDK6 | C0278510 | Childhood Medulloblastoma | 2 | CTD_human |
Hgene | CDK6 | C0278876 | Adult Medulloblastoma | 2 | CTD_human |
Hgene | CDK6 | C0751291 | Desmoplastic Medulloblastoma | 2 | CTD_human |
Hgene | CDK6 | C1275668 | Melanotic medulloblastoma | 2 | CTD_human |
Hgene | CDK6 | C2585653 | Persistent atrial fibrillation | 2 | CTD_human |
Hgene | CDK6 | C3468561 | familial atrial fibrillation | 2 | CTD_human |
Hgene | CDK6 | C0002871 | Anemia | 1 | CTD_human |
Hgene | CDK6 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Hgene | CDK6 | C0004403 | Autosome Abnormalities | 1 | CTD_human |
Hgene | CDK6 | C0008625 | Chromosome Aberrations | 1 | CTD_human |
Hgene | CDK6 | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | CDK6 | C0023452 | Childhood Acute Lymphoblastic Leukemia | 1 | CTD_human |
Hgene | CDK6 | C0023453 | L2 Acute Lymphoblastic Leukemia | 1 | CTD_human |
Hgene | CDK6 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | CDK6 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | CDK6 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
Hgene | CDK6 | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Hgene | CDK6 | C0263454 | Chloracne | 1 | CTD_human |
Hgene | CDK6 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Hgene | CDK6 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | CDK6 | C0677866 | Brain Stem Neoplasms | 1 | CTD_human |
Hgene | CDK6 | C0751886 | Brain Stem Neoplasms, Primary | 1 | CTD_human |
Hgene | CDK6 | C0751887 | Medullary Neoplasms | 1 | CTD_human |
Hgene | CDK6 | C0751888 | Mesencephalic Neoplasms | 1 | CTD_human |
Hgene | CDK6 | C0751889 | Pontine Tumors | 1 | CTD_human |
Hgene | CDK6 | C0751956 | Acute Cerebrovascular Accidents | 1 | CTD_human |
Hgene | CDK6 | C1168401 | Squamous cell carcinoma of the head and neck | 1 | CTD_human |
Hgene | CDK6 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Hgene | CDK6 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |
Hgene | CDK6 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |
Hgene | CDK6 | C3711387 | Autosomal Recessive Primary Microcephaly | 1 | ORPHANET |
Hgene | CDK6 | C4015156 | MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE | 1 | CTD_human;GENOMICS_ENGLAND;UNIPROT |